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Abstract In most cases, laryngomalacia presents as a
mild disease, and the symptoms resolve after wait-and-see
policy. Up to 20 % of patients present with severe laryn-
gomalacia and may require surgery (i.e. supraglottoplasty);
however, the indication for surgery is not firmly established
yet. The goal of this study is to determine whether supra-
glottoplasty results in a better outcome than wait-and-see
and to investigate how different comorbidities influence
outcome. A retrospective study of pediatric cases of in a
tertiary referral center was performed. Photo and video
documentation was available and revised in all cases.
Electronic and paper charts were reviewed for the follow-
ing variables: gender, sex, gestational age, birth weight,
symptoms, comorbidity, date of endoscopy, severity and
type of laryngomalacia, treatment modality and technique
and follow-up data and a total 89 patients were included.
Supraglottoplasty was found to lead to significantly faster
complete improvement of laryngomalacia than wait-and-
see policy (5 weeks vs. 29, p = 0.026). Synchronous air-
way lesions (SALs) were present in 40.4 % of patients and
were associated with prolonged symptoms of
laryngomalacia (38.5 weeks vs. 14.5, p = 0.043). Supra-
glottoplasty is safe and effective in treatment of severe
laryngomalacia. SALs and comorbidities are frequently
found in patients with laryngomalacia and are responsible
for longer onset of complaints.
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Introduction
Congenital laryngomalacia is the most common etiology
causing stridor in infants with a reported incidence of
35–75 % of patients [1]. Supraglottic structures collapse
into the airway during inspiration, causing airway
obstruction. In most cases laryngomalacia presents with
inspiratory, sometimes with in- and expiratory, stridor. The
stridor typically worsens with feeding, crying, supine
positioning, agitation and exercise. Typically, symptoms
are not present at birth, start within the first 4 months of
life and peak at an age of 4–8 months [2]. The most
common associated symptoms are swallowing dysfunction,
regurgitation, cough, sleep-disordered breathing [1, 3]. An
estimated 40 % of infants presenting with laryngomalacia
have mild and 40 % have moderate symptoms and can be
treated conservatively, spontaneously resolving at the age
of 12–24 months [1]. Up to 20 % of laryngomalacia
patients present with severe laryngomalacia. Severe
laryngomalacia is not likely to cure spontaneously, and is
more likely to require supraglottoplasty [4].
Laryngomalacia is a self-limiting disease. Nowadays,
treatment consists of either wait-and-see or endoscopic
surgery (supraglottoplasty). Previous studies have shown
that endoscopic surgical treatment is of additional value in
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the treatment of laryngomalacia [5, 6]. The experiences
with complications after supraglottoplasty are controversial
in the current literature. Studies related failure and com-
plications directly to comorbidities [7, 8], while other
studies have shown otherwise [5, 9, 10]. Various supra-
glottic structures can be affected in cases with laryngo-
malacia, as described in the Groningen Laryngomalcia
Classification System [11]. Most common findings are:
inward collapse of arytenoids cartilages (type 1), medial
displacement of aryepiglottic folds (type 2) and postero-
caudal displacement of epiglottis against the posterior
pharyngeal wall (type 3). Demonstrative video material of
these three types are available in the online version of the
manuscript (Videos 1–3). Most patients show combinations
of these dynamic abnormalities. The type of laryngoma-
lacia determinates the type of supraglottoplasty; type 1
laryngomalacia necessitate removing redundant supra-ary-
tenoid tissue, type 2 incision of the shortened aryepiglottic
folds, and type 3 epiglottopexy [11]. These surgical inter-
ventions can be combined.
The primary purpose of the present study is to evaluate
the best treatment policy in the treatment of laryngomala-
cia by comparing the short and long-term outcome of
patients with moderate and severe laryngomalacia treated
by either supraglottoplasty or wait-and-see policy. The
secondary aim was to identify predictors of treatment
outcome.
Materials and methods
All patients diagnosed with laryngomalacia between Jan-
uary 2002 and December 2012, less than 5 years of age at
the time of diagnosis, were included. All patients were
treated at the Department of Otorhinolaryngology, Head
and Neck Surgery of the University Medical Center
Groningen, The Netherlands, a tertiary referral center.
Patients were excluded if they underwent previous surgery
for other airway problems; if there was insufficient amount
of data for analysis; or when reviewing the endoscopic
documentation revealed another diagnosis than laryngo-
malacia. Imaging material was reviewed by the first author
(MvdH) under supervision of the two senior authors (FGD
and GBH).
A retrospective chart view of patients with laryngoma-
lacia was performed. Electronic patients’ charts were pri-
marily reviewed, and paper charts were reviewed if
additional data were needed. The following variables were
collected: gender, gestational age, birth weight, age at
diagnosis, presenting symptoms, severity of disease, type
of laryngomalacia (according to GLCS [11]), age at
endoscopy, synchronous airway lesions, performed
treatment, postoperative outcome, time from treatment
until free of symptoms, comorbidity and genetic disorders.
When laryngomalacia was suspected, diagnosis was
confirmed by flexible fiberoptic laryngoscopy under gen-
eral anesthesia. Patients were breathing spontaneously
throughout the procedure and evaluation of the airway was
performed, including assessment of synchronous airway
lesions. Rigid endoscopy was not performed routinely, only
on indication (e.g. therapeutic procedure). A division of
severity was made on clinical presentation and endoscopic
findings [7]. Severe laryngomalacia was established if
complaints included severe feeding difficulties, failure to
thrive, cyanosis or intercostal and/or xyphoidal retractions
or endoscopy showed significant dynamic airway
obstruction.
Reasons for supraglottoplasty were severe clinical pre-
sentation or insufficient spontaneous resolving of symp-
toms during exerting a wait-and-see policy.
Supraglottoplasty consisted of resection of supra-ary-
tenoidal redundant mucosa, incision of shortened
aryepiglottic folds, epiglottopexy or a combination of
these. Both removal of supra-arytenoidal redundant
mucosa and incision of the aryepiglottic folds were per-
formed with either cold steel instrumentation or (prefer-
ably) CO2 laser (0.8–1.5 W, superpulse, continuous mode,
spot size 200 lm). Epiglottopexy consisted of de-epithe-
lialization of the vallecula and suturing the lingual side of
the epiglottis to the base of the tongue. Airway manage-
ment consisted of either orotracheal intubation whether or
not with interrupted apnea, or (supraglottic) high frequency
jet ventilation (SHFJV).
Post-operative care depended on severity of preopera-
tive symptoms. It usually consisted of immediate extuba-
tion and one night observation with cardiorespiratory
monitoring. No preventive antibiotic treatment was
administered. Occasionally patients were treated with
dexamethasone (0.5–1 mg/kg). If no events occurred dur-
ing observation patients were discharged the day after
surgery.
Standard follow-up was performed 6 weeks after initial
endoscopy. The frequency of further controls was
depending on the complaints. Patients with no complaints
were dismissed from regular follow-up. If no/insufficient
improvement or progression of the symptoms occurred
after wait-and-see or supraglottoplasty, a second diagnostic
endoscopy was performed (median 43 weeks; range
260 weeks). If laryngomalacia was still apparent after wait-
and-see, this was called residual disease. If laryngomalacia
was still apparent after supraglottoplasty, it was called
recurrent disease. During the last control, severity of
symptoms was divided into no improvement, partial
improvement or complete improvement.
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Statistical analysis was performed using SPSS version
20.0. For comparison between groups we used the Mann–
Whitney U test. For correlations the Spearman test was
performed. Statistical significance was set at p\ 0.05.
Results
A total of 100 patients met our inclusion criteria, based on
the registered diagnosis. After analysis of data 11 patients
were excluded. Ten patients were excluded because of
misdiagnosis after reviewing photo/video documentation
and OR-reports [bilateral vocal cord paralysis (N = 5),
laryngeal web (N = 1), luxated arytenoids (N = 1), ret-
rognatia (N = 1) and tracheamalacia (N = 2)]. One patient
was excluded due to lack of data to objectify laryngoma-
lacia. In total, 89 patients remained for statistical analysis.
Table 1 shows characteristics of the study population
and Table 2 describes all treatment characteristics.
Comorbidity was found in 60 patients (67 %). The most
commonly found comorbidity was synchronous airway
lesions (SALs) with 36 cases (40 %), showing 54 airway
lesions: several patients had more than one synchronous
airway lesion. Table 3 shows the different synchronous
airway lesions found in this population. Cardiac comor-
bidity was found in 12 patients (13.5 %), neurologic
comorbidity in 8 patients (9.0 %), chromosomal/syndromal
disease in 23 patients (25.8 %) and other comorbidities
were found in 10 patients (11.2 %).
Presence of any comorbidity was related to more severe
form of laryngomalacia (p = 0.003). However, no dis-
tinction could be made between different types of comor-
bidities [SAL (p = 0.266), cardiac (p = 0.115), neurologic
(p = 0.247) or syndromal/genetic (p = 0.026)]. The co-
moborbidities showed no correlation with performed
treatment. Gestational age, sex, birth weight and age at
onset showed no correlations with performed treatment,
severity of disease or length of disease. Table 4 shows the
influence of comorbidity on the median time to complete
improvement. Patients with SALs needed a statistically
significant longer time for complete improvement
(p = 0.043). Although all factors showed difference in
median time to complete improvement, no other factors
were found to have significant influence on the time to
complete improvement. Gender, age at onset, gestational
age and birth weight was not related to laryngomalacia
severity or time to complete improvement. Multivariate
analysis could not be performed due to low number of
cases. Only one patient of patient treated with supraglot-
toplasty (7.1 %) had recurrent disease after supraglotto-
plasty. During primary supraglottoplasty of this patient,
redundant mucosa of only one arytenoid cartilage was
removed, based on asymmetric type 1 laryngomalacia.
Recurrent disease presented with contralateral type 1
laryngomalacia. During revision supraglottoplasty redun-
dant mucosa over the arytenoid cartilage of the contralat-
eral side was removed. In total 65 (73 %) patients were
Table 1 Patient characteristics of 89 patients treated for
laryngomalacia
Age in days, median (range)
Presentation of symptoms 60 (0–1691)




Gestational age in weeks. Mean (SD) 38 ? 4 (2 ? 5)
Birth weight in grams. Mean (SD) 3168.6 (850)





Feeding problems 12 (13)
Failure to thrive 5 (6)
Respiratory distress 11 (12)
Retractions 15 (17)
Other 3 (3)






Synchronous airway lesionsa 36 (40.4)
Cardialb 12 (13.5)
Neurologicalc 8 (9.0)
Syndrome/genetic disordersd 23 (25.8)
Othere 10 (11.2)
None 29 (32.6)
a See Table 2
b Tetralogy of Fallot (n = 2), ventricular septum defect (4), trans-
position of the great vessels (1), bicuspid aorta valves (1), atrioven-
tricular septum defect and AVSD with pulmonary hypertension (2) or
with overriding aorta (1)
c Epilepsy (n = 3), cerebral infarction (1), cerebral cyst (1),
Hirschsprung’s disease (1), gastroparesis and autism (1)
d Down syndrome (n = 5). Pierre Robin (3), CHARGE (3), Door
syndrome (2), West syndrome (2), congenital myasthenia syndrome
(1), Rubinstein Taybi syndrome (1), Freeman-Sheldon syndrome (1),
Goldenhar syndrome (1), Perlman syndrome (1), macrocephaly-cap-
illar malformation syndrome (1), Q7 syndrome and an unknown
mitochondrial syndrome (1)
e Hydronephrosis (n = 2), pylorus hypertrophy (1), nasal teratoma
(1), polycystic kidney disease (1), thyroglossal cyst (1), congenital
cataract (1), reflux and hernia umbilicalis combined with phimosis (1)
Eur Arch Otorhinolaryngol (2016) 273:1507–1513 1509
123
treated with a wait-and-see policy, 22 (24.7 %) with
supraglottoplasty and 2 (2.2 %) with tracheostomy. Of the
patients undergoing supraglottoplasty 17 (77.3 %) were
performed with CO2 laser and 3 (13.6 %) with cold steel
instruments.
Table 5 summarizes the follow up data. Follow-up data
were available in 62 patients (70 %). Complete improve-
ment was registered in 30 patients (34 % of total group). In
total seven patients died during their follow-up. None of
them died due to laryngomalacia: all died of other severe
comorbidities. Two patients received a tracheostomy. One
of them underwent tracheostomy because the laryngoma-
lacia did not improve and supraglottoplasty was not a
standard procedure in our institution yet. However, the
other tracheostomy was not related to laryngomalacia, but
was performed because of severe tracheamalacia. This was
the reason that this patient did not undergo previous
supraglottoplasty.
Table 6 demonstrates the complete improvement in
weeks in patients with different treatment and severity of
disease. All patients, who underwent supraglottoplasty,
achieved complete improvement within 6 weeks, except
three patients who achieved complete improvement in 31,
57 and 58 weeks. Supraglottoplasty showed significant
reduction of time to achieve complete improvement in the
whole population (p = 0.026). However, no statistically
significant difference was seen among the different sever-
ities of laryngomalacia, very likely due to insufficient
numbers. Groups, wait-and-see and supraglottoplasty,
matched for gender, age at onset, birth weight and gesta-
tional age.
Discussion
Laryngomalacia is a benign and self-limiting disease. The
present study confirms the additional value of supraglot-
toplasty in the treatment of laryngomalacia. We have
shown for the first time that supraglottoplasty shortens the
length of symptomatic disease, compared to wait-and-see
policy. This study also shows that comorbidity, especially
synchronous airway lesions, is associated with the severity
of disease. Comorbidity tends to negatively influence the
resolution of symptoms.
Comorbidity was found in two-thirds of our patients
(67 %). According to literature comorbidity is present in
around 25–47 % of patient with laryngomalacia, disre-
garding synchronous airway lesions (SALs) [8, 12, 13].
The higher incidence of comorbidity in our practice is very
likely due to the fact, that we also counted SALs as
comorbidities and also probably because of the higher ratio
of complex patients in our academic setting. Although no
other studies directly compared comorbidities with time to
complete improvement, comorbidity is found to be risk
factors for supraglottoplasty failure [12]. Preciado et al.
showed in their review that comorbidity is associated with
Table 2 Treatment characteristics of 89 patients treated for
laryngomalacia
Primary treatment (1st endoscopy), n (%)
Wait-and-see 75 (84.3)
Endoscopic surgery 14 (16.5)
Tracheostomy 0 (0.0)
Recurrent/residual disease (2nd endoscopy), n (%)
After wait-and-see 13 (17.3)
After surgery 1 (7.1)
Treatment of recurrent/residual disease, n (%)
Wait-and-see 3 (21.4)
Endoscopic surgery 9 (64.3)
Tracheostomy 2 (14.3)




Used technique, n (%)
CO2 laser 17 (77.3)
Cold steel 3 (13.6)
Epiglottopexy 2 (9.1)
Complications 0
Table 3 Distribution of synchronous airway lesions (SALs) in all
patients with laryngomalacia and SAL (n = 36)
Synchronous airway lesion n (%)








a Laryngeal web (2), bilateral vocal cord paralysis (1) and missing
lung lobe (1)
Table 4 Median time in weeks to achieve complete improvement
related to comorbidities in patients with laryngomalacia, regardless of
treatment modality used
Present (n) Not present (n) p
Comorbidities 31.0 (23) 15.0 (7) 0.116
Cardial 51.0 (5) 26.0 (25) 0.373
Neurologic 40.0 (5) 26.0 (25) 0.845
Syndromal 45.0 (6) 25.5 (24) 0.243
SAL 38.5 (18) 14.5 (12) 0.043
Bold value indicates statistically significant p value (p\ 0.05)
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a more than sevenfold increased risk of surgical failure.
Furthermore, otherwise healthy patients have significantly
lower risk of post supraglottoplasty aspiration [14, 15].
Durvasula et al. related especially neurologic and syn-
dromic comorbidities with a supraglottoplasty failure [16].
We noted relation between the severity of laryngomalacia
and occurrence of comorbidity in general. Furthermore,
there also seems to be a negative relation between
comorbidity and time to achieve complete improvement;
however, this was not statistically significant (p = 0.116).
The clinical significance of SALs in patients with laryn-
gomalacia is a rather controversial subject. Studies reporting
a high incidence of SALs suggest that SALs are related to
disease severity and patients with SALs are therefore more
likely to require surgery [17, 18]. Our results suggest that the
presence of SALs in patients with laryngomalacia is asso-
ciated with worse long-term outcome but it is not associated
to the severity of disease. On the other hand some studies
report no clinical significance of SALs with no influence on
time to complete improvement [19, 20], and no association
between severity and SALs [21]. The most common repor-
ted SAL in our cohort is tracheamalacia (39 %). This is in
agreement with other studies [7, 22].
Prevalence of cardiac comorbidity ranges between 10
and 17.9 % in patients with laryngomalacia in the literature
[2, 8, 23]. Patients with cardiac comorbidities have a higher
chance of revision supraglottoplasty or tracheostomy and
are associated with increased severity [8]. This could not
be confirmed by our data. However, cardiac impairment
was of negative influence on time to achieve complete
improvement, but this correlation was not statistically
significant (p = 0.373).
Neurologic impairment is thought to influence laryn-
gomalacia severity and outcome [2, 8, 12, 16, 17, 24, 25].
All these studies related neurologic comorbidity to
increased chance of revision supraglottoplasty and tra-
cheostomy. However, we cannot relate neurologic comor-
bidities to worse outcome in our series, as the patient with
revision supraglottoplasty and the two tracheostomy cases
did not have any neurologic conditions.
The reported incidence of syndromal and genetic disor-
ders ranges from 8 to 20 % [1]. Down syndrome, CHARGE
and Pierre Robin are the most frequently seen disorders in
literature and also in our population [8]. However, the sig-
nificance of the presence of syndromal/genetic disorders has
not been well examined. Syndromes associated with ret-
rognathia, like CHARGE and Pierre Robin sequence, are
more likely to fail supraglottoplasty [8, 16, 26]. Our data
show that syndromal/genetic disorders are related to the
severity of disease. Our data show a trend that patients with
syndromal/genetic disorders need more time to achieve
complete improvement than other patients (p = 0.243).
We found only one patient with gastroesophageal reflux
disease (GERD), where the reported incidence is between
65 and 100 % [1, 27, 28]. A systematic review of 27
studies showed coexistence between GERD and laryngo-
malacia. However, due to limited evidence no causal
connection could be made [27]. Due to the retrospective
nature of the underlying study it is hard to determine
whether reflux was not present. However, video and photo
documentation showed no convincing signs of GERD.
Studies reporting high incidence lack a control group, thus
the clinical significance of the presence of GERD has not
been well established [27]. Most probably, considering
literature data, GER and not GERD was present in our
cohort but not documented. The presence of GERD and the
clinical significance of it should be further examined.
A noteworthy finding in our study is the low amount of
revision supraglottoplasty, tracheostomies and complica-
tions. Hoff et al. described a higher rate of revision
Table 5 Outcome of performed
treatment in complete group of
62 patients with
laryngomalacia, depending on
final treatment (n (%))
Final treatment Total
Supraglottoplasty Wait-and-see Tracheotomy
Deceaseda 2 5 0 7
No improvement 1 (4,5) 2 (5.3) 1 4
Partial improvement 9 (40.1) 12 (31.6) 0 21
Complete improvement 10 (45.4) 19 (50.0) 1 30
Total 22 (100) 38 (100) 2 62
a Causes of death (all causes occurred once): kidney cancer, epilepsy, tracheamalacia, Freeman-Sheldon
syndrome, sepsis, unidentified syndrome, unknown (but not suspicious for laryngomalacia)
Table 6 Median time in weeks (n) to achieve complete improve-
ment, depending on severity of disease, and depending on treatment
applied
Laryngomalacia Wait-and-see Supraglottoplasty p
Mild 32 (13) –
Moderate 53 (3) 3 (1) 0.180
Severe 10 (3) 6 (9) 0.778
All severities 29 (19) 5 (10) 0.026
Bold value indicates statistically significant p value (p\ 0.05)
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supraglottoplasty (15.2 vs. 47.8 %) and tracheostomy
depending on the presence of comorbidity (0 vs. 39.1 %)
[8]. Other studies showed a range of 4.4–34.6 % of patients
required either revision supraglottoplasty or tracheostomy
after primary supraglottoplasty [12, 29, 30]. Although
complications are rare [31], supraglottic stenosis is a
known complication of supraglottoplasty with a reported
incidence of 3.7 % [12].
Most of our patients (77.3 %) were operated with CO2
laser, with superpulse mode, which is comparable with other
authors [8, 29]. Superpulse mode allows the tissue to cool
down between two impulses, therefore minimizing tissue
damage. Rastatter et al. used both CO2 laser and cold
instruments techniques. Only in the CO2 laser supraglotto-
plasty group three patients needed tracheostomy [30], sug-
gesting CO2 laser to be less safe. In contrast, 80 % of
patients in the study of Denoyelle et al. [12], with a reported
rate of 3.7 % laryngeal stenosis, were operated using cold
steel micro-instruments. Other factors, like the application of
dexamethasone or supraglottic high frequency jet ventilation
(SHFJV) [32], which improves surgical precision by pro-
viding good exposure of the operating area, might have also
contributed to our low complication rate.
Without doubt, there are some weaknesses of the present
study. Missing data were to be expected due to the retro-
spective nature of this study because of incomplete data
registration in the paper and electronic charts. In addition,
this study contained insufficient numbers to perform a
multivariate analysis. Patients with more severe disease
were more likely to undergo supraglottoplasty, resulting in
a selection bias in the operated group of patients. Some
patients with supraglottoplasty indicated at the second
endoscopy were already candidates for surgery at the initial
endoscopy. Despite this potential selection bias, patients
who underwent supraglottoplasty were found to need sig-
nificantly shorter time to achieve complete improvement.
A prospective, multicenter study could solve these prob-
lems; however, uniformity in diagnostics and treatment
might be the drawback of such a study.
Conclusion
To our best knowledge, this is the first study relating the
outcome of supraglottoplasty with time. Our results show
that supraglottoplasty is beneficial in the treatment of
patients with severe laryngomalacia by significantly
reducing the time to improvement of the complaints. Fur-
thermore, comorbidity is found to have influence on the
duration and severity of laryngomalacia.
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